ASML's July 15 Reckoning: Can AI Demand Outweigh China Risks and a High-NA Pause?
03.07.2026 - 04:51:06 | boerse-global.de
ASML shares ended Thursday at €1,550, more than 11% below the all-time high of €1,748.00 struck on June 30. That record rally was fuelled by Elon Musk's public endorsement of the Dutch lithography giant as "Europe's best company" and his virtual appearance at an internal ASML conference, where he unveiled the Terafab project — a colossal semiconductor manufacturing network backed by SpaceX, Tesla, xAI and Intel, with initial investment of $55 billion and a potential full build-out costing up to $119 billion.
The subsequent retreat, however, has been equally dramatic. Yet the stock still sits on year-to-date gains of more than 56%, and the decline has been orderly rather than panicked. The real story is the collision of two powerful narratives: the AI-driven semiconductor boom that Musk's Terafab epitomises, and the gathering geopolitical storm over export controls.
The recent sell-off was triggered by the Dutch government's formal adhesion to the US-led Pax Silica alliance, stoking expectations of tighter multilateral restrictions on chip-making equipment. Washington is also probing whether technology is reaching China via third countries. For ASML, which counts China as roughly 20% of its planned 2026 system revenue, the stakes could hardly be higher. The company has already taken the unusual step of publishing a complete inventory of all 314 active and 26 decommissioned EUV machines worldwide to prove that none have reached China — a move analysts see as a savvy bid to reassure Western regulators.
Against this backdrop, ASML's second-quarter earnings on 15 July 2026 take on outsized importance. The central question: can the order momentum from artificial intelligence offset a potential downturn in Chinese demand? Or will the combination of stricter export rules and delayed adoption of ASML's next-generation High-NA EUV systems begin to weigh visibly on revenue?
Should investors sell immediately? Or is it worth buying Asml?
CEO Christophe Fouquet, who took the helm in early 2024, has positioned ASML as a pillar of European tech sovereignty while warning Brussels not to meddle directly in strategic industrial projects. The numbers on July 15 will test that balancing act. Management has guided for Q2 revenue between €8.4 billion and €9.0 billion, with a gross margin of 51–52% — a noticeable step down from the 53% recorded in the first quarter. The company attributes the margin compression to a more normal product and customer mix, after Q1 benefited from an unusually favourable configuration.
The bull case rests on an order book that remains swollen by AI infrastructure spending. ASML still expects full-year 2026 revenue of between €36 billion and €40 billion, a gross margin of 51–53%, and an effective tax rate of around 17%. The stock trades 35% above its 200-day moving average of €1,144.92, suggesting a structural growth trend rather than a cyclical peak. Some Wall Street analysts see the recent weakness as a buying opportunity, with hopes that ASML will offer more clarity on demand extending into 2027 for both EUV and DUV systems.
The bears, however, point to real headwinds. Key customers including TSMC are postponing the switch to ASML's expensive High-NA EUV machines, preferring cheaper advanced-packaging alternatives. That slows the conversion of the massive order backlog into revenue. Meanwhile, China's pull from older systems is fading as the pre-buying wave runs its course. The market's jitters are captured by a 30-day annualised volatility reading of 61.48% — an elevated level that underscores how any fresh headline can swing the stock.
Asml at a turning point? This analysis reveals what investors need to know now.
Technically, the shares are roughly 8% above the 50-day average of €1,434, but the relative strength index sits at a neutral 49.9. A decisive push back above the 50-day line would signal renewed upward momentum. Conversely, a slide towards the 100-day moving average of €1,317.34 would indicate that China concerns and High-NA delays are overpowering the AI growth story.
For now, the bull case retains the upper hand, reinforced by Musk's Terafab vision and the structural tailwind of AI. But the July 15 earnings release is the next critical gate. Investors will be watching revenue and gross margin against those Q2 targets — and scanning the management commentary for any hint that geopolitical friction is beginning to damage a still-stellar outlook.
Ad
Asml Stock: New Analysis - 3 July
Fresh Asml information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
